Knowledge Bank

Psoriasis is a multifaceted disorder known to primarily affect keratinocytes, blood vessels, and the immune system. The CD1 KC-­Tie2 murine model manifests symptoms analogous to those experienced by those 125 million psoriasis patients worldwide. In order to investigate the underlying causes a topical treatment, solenopsin, was applied to the psoriasiform model. After four weeks, decrease in epidermal thickness was noted. Additionally, CD4+ T cells, CD8+ T cells, and CD11c+ dendritic cells numbers were significantly reduced. Measurements of hallmark mRNA transcripts further demonstrate to reduction of T cell numbers and their downstream products. The data collected suggest control of the T‐helper17 pathway, via application of topical solenopsin, reinstates the wild type phenotype for the KC‐Tie2 model.